Glucose Health, Inc.
Other OTCTotal Valuation
Glucose Health, Inc. carries a market capitalization of 6.26M, placing it among publicly traded companies globally.
| Market Cap | 6.26M |
| Enterprise Value | N/A |
Share Statistics
Glucose Health, Inc. currently has 4.52M shares outstanding.
| Shares Outstanding | 4.52M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 9.75, and the price-to-book ratio stands at -0.14.
| PE Ratio | N/A |
| PS Ratio | 9.75 |
| PB Ratio | -0.14 |
| P/TBV Ratio | -1.59 |
| P/FCF Ratio | -49.81 |
| P/OCF Ratio | -49.81 |
Financial Position
Glucose Health, Inc. maintains a current ratio of 0.06, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.06 |
| Quick Ratio | 0.06 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -5.59 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -241.95 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 5.62 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 9.51 |
Stock Price Statistics
Glucose Health, Inc.'s stock has gained approximately 304.3956% over the past 52 weeks. The 50-day moving average sits at 0.37, while the 200-day moving average is 0.23.
| Beta (5Y) | N/A |
| 52-Week Price Change | 304.3956% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | 0.23 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Glucose Health, Inc. generated 88,130.00 in revenue and converted that into -85,062.00 in net income, yielding earnings per share of -0.02. EBITDA reached -32,404.00, while operating income came in at -32,449.00.
| Revenue | 88,130.00 |
| Gross Profit | 57,626.00 |
| Operating Income | -32,449.00 |
| Pretax Income | -85,062.00 |
| Net Income | -85,062.00 |
| EBITDA | -32,404.00 |
| EBIT | -32,449.00 |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
Total book value stands at -6.20M, with working capital of -426,427.00 providing operational flexibility.
| Cash & Cash Equivalents | 16,636.00 |
| Total Debt | N/A |
| Net Debt | 316,241.00 |
| Equity (Book Value) | -6.20M |
| Book Value Per Share | -1.66 |
| Working Capital | -426,427.00 |
Cash Flow
Glucose Health, Inc. produced -17,253.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -17,253.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -17,253.00 |
| FCF Per Share | 0.00 |
Margins
Glucose Health, Inc. operates with a gross margin of 65.39, reflecting its pricing power and cost economics. The operating margin of -36.82 and net profit margin of -96.52 provide insight into operational efficiency.
| Gross Margin | 65.39 |
| Operating Margin | -36.82 |
| Pretax Margin | -96.52 |
| Profit Margin | -96.52 |
| EBITDA Margin | -36.77 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -1.16 |
| FCF Yield | -2.01 |
Stock Splits
Glucose Health, Inc.'s most recent stock split took place on November 17, 2014 with a 50:1 split ratio.
| Last Split Date | 11/17/2014 |
| Split Ratio | 50:1 |
Scores
Glucose Health, Inc. posts an Altman Z-Score of -351.44, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -351.44 |